Clinical Trials Logo

Clinical Trial Summary

The age-related loss in skeletal muscle mass is associated with substantial social and economic costs as evidenced by impairments in strength, limitations in function, and ultimately, physical disability and institutionalization (1-3). Improved knowledge of the physiologic mechanisms that mediate impairments in physical functioning is crucial for developing effective therapeutic interventions for preserving mobility and independence among physically frail adults.

To date, pharmacodynamic markers that can be used in a clinical trial in mobility-limited older adults are limited. Lean body mass measured by dual energy X-ray absorptiometry (DXA) is frequently used in early phase clinical development of investigational anabolic drugs. Although increase in muscle mass is considered to contribute to increased muscle strength, this alone does not completely explain changes in physical performance. Thus, more direct pharmacodynamic evidence associated with physical functioning is desired in early phase clinical development decision making. Assessments of muscle power and fatigue can address this need. The use of such assessments may provide more meaningful information as to the pharmacodynamics effects of investigational drugs on muscle parameters.

This study will serve as a validation study, aiming to 1) examine the effect a 12-week resistance program may have on muscle power and fatigue; 2) examine the effect of a 12-week resistance exercise program on conventional measures of muscle function; 3) determine the relationship between muscle power/fatigue and conventional measures of physical function. Data from this study will serve as rationale for potentially including these measures as pharmacodynamics markers in studies of novel therapies for skeletal muscle loss and/or weakness.


Clinical Trial Description

The age-related loss in skeletal muscle mass is associated with substantial social and economic costs as evidenced by impairments in strength, limitations in function, and ultimately, physical disability and institutionalization (1-3). Improved knowledge of the physiologic mechanisms that mediate impairments in physical functioning is crucial for developing effective therapeutic interventions for preserving mobility and independence among physically frail adults.

To date, pharmacodynamic markers that can be used in a clinical trial in mobility-limited older adults are limited. Lean body mass measured by dual energy X-ray absorptiometry (DXA) is frequently used in early phase clinical development of investigational anabolic drugs. Although increase in muscle mass is considered to contribute to increased muscle strength, this alone does not completely explain changes in physical performance. Thus, more direct pharmacodynamic evidence associated with physical functioning is desired in early phase clinical development decision making. Assessments of muscle power and fatigue can address this need. For example, Bean et al reported that improvements in leg power, independent of strength, appear to make an important contribution to clinically meaningful improvements in SPPB (Short Physical Performance Battery) and gait speed (4). Avin and Frey Law performed a systematic meta-analysis of studies reporting fatigue tasks (voluntary activation) performed at a relative-intensity in both young (18-45 years of age) and old (>54 years of age) healthy adults to conclude older adults were able to sustain relative-intensity tasks significantly longer or with less force decay than younger adults although this age-related difference was present only for sustained and intermittent isometric contractions and this age-related advantage was lost for dynamic tasks (5). The use of such assessments may provide more meaningful information as to the pharmacodynamics effects of investigational drugs on muscle parameters.

This study will serve as a validation study, aiming to 1) examine the effect a 12-week resistance program may have on muscle power and fatigue; 2) examine the effect of a 12-week resistance exercise program on conventional measures of muscle function; 3) determine the relationship between muscle power/fatigue and conventional measures of physical function. Data from this study will serve as rationale for potentially including these measures as pharmacodynamics markers in studies of novel therapies for skeletal muscle loss and/or weakness. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03083275
Study type Interventional
Source Tufts University
Contact
Status Completed
Phase N/A
Start date January 3, 2016
Completion date February 15, 2017

See also
  Status Clinical Trial Phase
Not yet recruiting NCT06396247 - Impact of Brief Daily Functional Resistance Training on Lower Extremity Physical Performance Phase 2/Phase 3
Not yet recruiting NCT05975476 - Comparison of Two Park-Based Activities on Emotional Well-Being in Adults With Mobility Impairments N/A
Completed NCT01647802 - Cross-over Study of Three Modular Devices for Aid in Patient Standing and Transfer N/A
Completed NCT01614392 - Lower Extremity Muscle and Function in the Elderly: Study 2 N/A
Enrolling by invitation NCT05736484 - Randomized Clinical Trial to Improve Mobility After Hospitalization N/A
Active, not recruiting NCT05678985 - Evaluating Impact and Implementation of Choose to Move (Phase 4) N/A
Completed NCT06025656 - Assessment of the Reliability and Validity of the Leg Lateral Reach Test in Adolescent Tennis Players N/A
Completed NCT04760392 - Goal-directed Mobilization of Medical Inpatients N/A
Enrolling by invitation NCT06434298 - Provincial Scale-up of Choose to Move (CTM) Phase 4 N/A
Recruiting NCT05516030 - HIFT for People With Mobility-Related Disabilities N/A
Not yet recruiting NCT06264362 - Developing a Nonpharmacological Pain Intervention for Community-dwelling Older Adults With Dementia N/A
Withdrawn NCT04044846 - Promoting Movement in Older Adults in the Community N/A
Terminated NCT03558841 - Effect of Lyra Gait Training on the Mobility of Geriatric Rehabilitation Inpatients N/A
Not yet recruiting NCT03675490 - ABLE (Arts-Based Exercise Enhancing LongEvity) N/A
Completed NCT02913963 - Changes on Pain and Range of Motion by the Use of Kinesio Taping in Subjects With Myofascial Trigger Point N/A
Completed NCT02913976 - Changes on Pain and Range of Motion by the Use of Kinesio Taping in Patients Diagnosed With Cervical Pain N/A
Completed NCT05081856 - Use Modular Medical Equipment Vehicle in Mobilization of Patient With Chest Tube N/A
Withdrawn NCT02298374 - Evaluation of Homecare Reablement, the Trondheim Model N/A
Completed NCT02498704 - Dry Needling and Stretching vs. Stretching Alone on Hamstring Flexibility in Patients With Knee Pain N/A
Completed NCT00177359 - Restoring Skill in Walking Phase 2